Related Experiment Videos
Sulphasalazine treatment in protracted familial Mediterranean fever arthritis
Sevcan A Bakkaloglu1, Tekin Aksu, Berna Goker
1Department of Pediatrics, Gazi University, Ankara, Turkey.
Abstract:
Familial Mediterranean fever (FMF) is an autosomal recessive disease characterized by self-limited attacks of fever and polyserositis. Articular involvement in early-onset FMF is a common finding characterized by non-erosive, generally asymmetric monoarthritis in large joints. Protracted FMF arthritis was reported in 2.6% of Turkish patients. An 8-year-old female who has a history of FMF for 5 years applied to our hospital with complaints of persistent swelling and pain of her left knee for 8 months. The patient had been tried to be managed with non-steroidal anti-inflammatory drugs as well as intra-articulary steroids and colchicine. However, arthritis and acute phase response persisted. With sulphasalazine, complete recovery was achieved. It is our belief that sulphasalazine can be a choice of medical treatment in protracted FMF arthritis.
Insights
Familial Mediterranean Fever (FMF) arthritis can be challenging to treat. Sulphasalazine effectively resolved persistent knee arthritis and inflammation in a pediatric FMF patient unresponsive to other therapies.
Area of Science:
- Rheumatology
- Genetics
- Pediatrics
Background:
- Familial Mediterranean Fever (FMF) is an autosomal recessive autoinflammatory disease.
- Articular involvement, specifically monoarthritis in large joints, is a common manifestation in early-onset FMF.
- Protracted FMF arthritis affects a small percentage of patients, posing treatment challenges.
Observation:
- An 8-year-old female with a 5-year history of FMF presented with 8 months of persistent left knee swelling and pain.
- The patient's arthritis and acute phase response were refractory to non-steroidal anti-inflammatory drugs, intra-articular steroids, and colchicine.
- Complete recovery was achieved after initiating sulphasalazine treatment.
Findings:
- Sulphasalazine demonstrated significant efficacy in managing protracted FMF arthritis.
- This case highlights a successful therapeutic outcome in a patient with refractory FMF arthritis.
- The patient experienced complete resolution of joint symptoms and inflammatory markers.
Implications:
- Sulphasalazine may represent a valuable therapeutic option for refractory or protracted FMF arthritis.
- This finding could guide treatment strategies for similar challenging FMF cases in pediatric populations.
- Further research into sulphasalazine's role in FMF management is warranted.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Rocky Mountain Spotted Fever
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...